These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16456542)

  • 1. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.
    Takahashi Y; Morales FC; Kreimann EL; Georgescu MM
    EMBO J; 2006 Feb; 25(4):910-20. PubMed ID: 16456542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
    Pan Y; Weinman EJ; Dai JL
    Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NHERF1: molecular brake on the PI3K pathway in breast cancer.
    Georgescu MM
    Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity.
    Maudsley S; Zamah AM; Rahman N; Blitzer JT; Luttrell LM; Lefkowitz RJ; Hall RA
    Mol Cell Biol; 2000 Nov; 20(22):8352-63. PubMed ID: 11046132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
    FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-induced recruitment of Na+/H+-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF.
    Demoulin JB; Seo JK; Ekman S; Grapengiesser E; Hellman U; Rönnstrand L; Heldin CH
    Biochem J; 2003 Dec; 376(Pt 2):505-10. PubMed ID: 12967325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation.
    Molina JR; Morales FC; Hayashi Y; Aldape KD; Georgescu MM
    Cancer Res; 2010 Sep; 70(17):6697-703. PubMed ID: 20736378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NHERF2 increases platelet-derived growth factor-induced proliferation through PI-3-kinase/Akt-, ERK-, and Src family kinase-dependent pathway.
    Jung Kang Y; Su Jeon E; Jin Lee H; Oh YS; Suh PG; Sup Jung J; Donowitz M; Ho Kim J
    Cell Signal; 2004 Jul; 16(7):791-800. PubMed ID: 15115658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration.
    James MF; Beauchamp RL; Manchanda N; Kazlauskas A; Ramesh V
    J Cell Sci; 2004 Jun; 117(Pt 14):2951-61. PubMed ID: 15161943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands.
    Morales FC; Takahashi Y; Momin S; Adams H; Chen X; Georgescu MM
    Mol Cell Biol; 2007 Apr; 27(7):2527-37. PubMed ID: 17242191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
    Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
    Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the PDZ1 domain of human Na(+)/H(+) exchanger regulatory factor provides insights into the mechanism of carboxyl-terminal leucine recognition by class I PDZ domains.
    Karthikeyan S; Leung T; Birrane G; Webster G; Ladias JA
    J Mol Biol; 2001 May; 308(5):963-73. PubMed ID: 11352585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression.
    Yang L; Wang Y; Chen P; Hu J; Xiong Y; Feng D; Liu H; Zhang H; Yang H; He J
    Endocrinology; 2011 Dec; 152(12):4537-49. PubMed ID: 21990315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of NHERF-1, NHERF-2, PDGFR-alpha, and PDGFR-beta in normal human kidneys and in renal transplant rejection.
    Weinman EJ; Lakkis J; Akom M; Wali RK; Drachenberg CB; Coleman RA; Wade JB
    Pathobiology; 2002-2003; 70(6):314-23. PubMed ID: 12865627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer.
    Conley-LaComb MK; Huang W; Wang S; Shi D; Jung YS; Najy A; Fridman R; Bonfil RD; Cher ML; Chen YQ; Kim HC
    Am J Pathol; 2012 Mar; 180(3):1017-1027. PubMed ID: 22209699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR.
    Zhang H; Bajraszewski N; Wu E; Wang H; Moseman AP; Dabora SL; Griffin JD; Kwiatkowski DJ
    J Clin Invest; 2007 Mar; 117(3):730-8. PubMed ID: 17290308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles for NHERF1 and NHERF2 on the regulation of C3a receptor signaling in human mast cells.
    Subramanian H; Gupta K; Ali H
    PLoS One; 2012; 7(12):e51355. PubMed ID: 23284683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
    Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
    Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory roles of NHERF1 and NHERF2 in cell surface expression of the glutamate transporter GLAST.
    Sato K; Otsu W; Otsuka Y; Inaba M
    Biochem Biophys Res Commun; 2013 Jan; 430(2):839-45. PubMed ID: 23200831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive diffuse activation of phosphoinositide 3-kinase at the plasma membrane by v-Src suppresses the chemotactic response to PDGF by abrogating the polarity of PDGF receptor signalling.
    Platek A; Vassilev VS; de Diesbach P; Tyteca D; Mettlen M; Courtoy PJ
    Exp Cell Res; 2007 Apr; 313(6):1090-105. PubMed ID: 17335807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.